(Source: Given Imaging Ltd) Given Imaging Announces Data Confirming PillCam(R) SB Improves Monitoring and Management of Crohn's Disease -- Additional Study Highlights Improved Diagnostic Yield for New 12-Hour PillCam SB -- -- Celebrates Two Millionth PillCam Milestone -- ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced new studies that confirm the value of PillCam SB in diagnosing, monitoring and managing patients with known or suspected Crohn's disease and other conditions of the small bowel. The studies were presented at Digestive Disease Week® (DDW), taking place...
↧